Comparison Between Two Different Volumes of Anesthesia Drug in Forearm Surgery
NCT ID: NCT01216488
Last Updated: 2011-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
72 participants
INTERVENTIONAL
2010-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to show that the anesthesia efficiency is the same with 40 or 25 ml of Xylocaine 1.5% Adrenalin in Forearm or Arm Surgery.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* age \> 18 years old
* patient who must have a non emergency surgery of the forearm or the hand
* ASA I or ASA II
* informed consent
* Ensured patient
Exclusion criteria :
* pregnancy
* respiratory insufficiency
* cardiac insufficiency
* hepatic insufficiency
* renal insufficiency
* ASA III or IV
* contraindications to the locoregional anesthesia
* contraindications to the xylocaine used
* patient participate to an another clinical study
* guardianship patient
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
40 ml of Xylocaine
Xylocaine
40 ml or 25 ml of Xylocaine injection
25 ml of Xylocaine
Xylocaine
40 ml or 25 ml of Xylocaine injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xylocaine
40 ml or 25 ml of Xylocaine injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient who must have a non emergency surgery of the forearm or the hand
* ASA I or ASA II
* informed consent
* Ensured patient
Exclusion Criteria
* respiratory insufficiency
* cardiac insufficiency
* hepatic insufficiency
* renal insufficiency
* ASA III or IV
* contraindications to the locoregional anesthesia
* contraindications to the xylocaine used
* patient participate to an another clinical study
* guardianship patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François PICART, MD
Role: PRINCIPAL_INVESTIGATOR
CHRU Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesia CHRU Brest
Brest, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RB09-060
Identifier Type: -
Identifier Source: org_study_id